EQT related stories
All articles and analysis
EQT mulls long-term vehicle to hold companies throughout life cyclesThe firm has also 'materially concluded' fundraising for its latest flagship, chief executive Christian Sinding said on its earnings call on Wednesday.
Three things to know about EQT's growth strategyEQT Growth will invest between €50m and €200m in mostly European companies focused on B2B tech, healthcare tech and impact tech.
Side Letter: EQT's growth plans, Apollo's impact, CalPERS' need for PEEQT has brought in another heavyweight to help get its growth platform off the ground. Plus: Apollo's impact framework, private credit default rates and more. Here's today's brief, for our valued subscribers only.
Side Letter: The Epstein connection; heard at the CFOs & COOs Forum; Pictet's tech targetThe link between Jeffrey Epstein and Apollo founder Leon Black continues to dog the latter: the latest developments on that below. Meanwhile, our virtual CFOs & COOs event is currently in full swing. Plus: Pictet targets tech, Riverside adds two, and more. Here's today's brief, for our valued subscribers only.
KKR amasses more than $13bn for record Asia fundKKR Asian Fund IV, which has been in market since March, is already 40% larger than its 2017-vintage predecessor.
Value creation: Four key learnings from the OpEx AwardsThe Operational Excellence Awards include a range of winners that provide examples of how to successfully execute value creation plans.
Operational Excellence Awards 2020: Winners revealedPrivate Equity International’s annual Operational Excellence Awards celebrate standout value creation stories in the private equity industry.
OpEx Awards winner Asia-Pacific: EQT – LBX PharmacyStore numbers increased more than 40-fold at LBX Pharmacy as EQT harnessed growth opportunities in the Chinese market.
Nordic giants to beat pandemic worries with largest-ever fundsScandinavia-headquartered PE firms are set to raise record amounts of capital amid a tougher environment due to coronavirus.
Ex-EQT execs close oversubscribed debut fund for DACHEOS Fund I follows a period of deal-by-deal investing for the lower-mid-market focused firm.